Kumar Budur, MD, MS, is the Chief Medical and Scientific Officer at Harmony Biosciences. He leads R&D strategy and Medical Affairs for Harmony Biosciences, and oversees the functional areas of Clinical strategy, Clinical Operations, Regulatory Affairs, Pharmacovigilance, Biostatistics, Portfolio Management and Medical Affairs.
Prior to Harmony Biosciences, Dr. Budur spent approximately 6 years each at AbbVie and Takeda, where he held positions of increasing responsibilities. A nationally recognized expert in Research and Development, he has overseen programs ranging from late discovery, early clinical development to late clinical development, and post-marketing studies. He has experience in progressing small molecules, biologics, drug-device combination through various stages of Development. Dr. Budur was involved with four New Drug Applications (NDAs) and was the lead for the registration clinical trials, submission, and approval process of two NDAs.
Dr. Budur was trained at Cambridge University in the UK, and Cleveland Clinic and completed his Residency in Psychiatry and Fellowships in Neurophysiology and Sleep Medicine. He is Board Certified in Psychiatry and Sleep Medicine and holds a master’s degree in clinical research from Case Western Reserve University. Dr. Budur has published over 45 original research papers in peer reviewed journals, edited four books, and chaired National and International seminars and symposiums.
What is Kumar Budur's net worth?
The estimated net worth of Kumar Budur is at least $484.99 thousand as of September 18th, 2026. Dr. Budur owns 13,115 shares of Harmony Biosciences stock worth more than $484,993 as of October 26th. This net worth approximation does not reflect any other assets that Dr. Budur may own. Learn More about Kumar Budur's net worth.
How do I contact Kumar Budur?
Has Kumar Budur been buying or selling shares of Harmony Biosciences?
Kumar Budur has not been actively trading shares of Harmony Biosciences during the last quarter. Most recently, Kumar Budur sold 35,852 shares of the business's stock in a transaction on Friday, September 18th. The shares were sold at an average price of $43.05, for a transaction totalling $1,543,428.60. Following the completion of the sale, the insider now directly owns 13,115 shares of the company's stock, valued at $564,600.75. Learn More on Kumar Budur's trading history.
Who are Harmony Biosciences' active insiders?
Are insiders buying or selling shares of Harmony Biosciences?
In the last year, insiders at the sold shares 8 times. They sold a total of 123,046 shares worth more than $5,040,776.09. The most recent insider tranaction occured on September, 18th when insider
Kumar Budur sold 35,852 shares worth more than $1,543,428.60. Insiders at Harmony Biosciences own 11.0% of the company.
Learn More about insider trades at Harmony Biosciences. Information on this page was last updated on 9/18/2026.